1 Min Read
March 28 (Reuters) - Cumberland Pharmaceuticals Inc
* Cumberland Pharmaceuticals Inc says Caldolor demonstrates significant post surgical pain reduction and decrease in opioid use Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.